Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2018-10-23 19:13:23
Reporting Period:
Accepted Time:
2018-10-23 19:13:23
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1557746 Aclaris Therapeutics Inc. ACRS Pharmaceutical Preparations (2834) 460571712
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1590102 Anand Mehra 3000 Sand Hill Road, Bldg. 4,
Suite 250
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-10-22 372,093 $10.75 1,911,573 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
  1. Such shares of the Company's Common Stock are owned by Sofinnova Venture Partners VIII, L.P. ("Sofinnova VIII"). The Reporting Person is a managing member of Sofinnova Management VIII, L.L.C., the general partner of Sofinnova VIII, and as such may be deemed to have shared voting and dispositive power over such shares with James I. Healy and Michael F. Powell, the other managing members of Sofinnova Management VIII, L.L.C. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of any pecuniary interest therein.